Gamma-Linolenic acid
|
Basic information |
| Metabolite name | Gamma-Linolenic acid |
 | HMDB0003073 |
 |
C06426 |
 |
5280933 |
| Synonyms | Gamma-Linolenic acid; |
| No. of studies | 5 |
|
Basic information |
| Metabolite name | Gamma-Linolenic acid |
| HMDB0003073 |
|
C06426 |
|
5280933 |
| Synonyms | Gamma-Linolenic acid; |
| No. of studies | 5 |
|
Relationship between Gamma-Linolenic acid and depression (count: 5) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1063 | Type1 | MDD group vs. control group | Plasma | Human | Up |
| Study M1111 | Type1 | CUMS group vs. control group | Hippocampus | C57BL/6 mouse | Down |
| Study M1111 | Type1 | CUMS group vs. control group | Plasma | C57BL/6 mouse | Down |
| Study M1142 | Type2 | MDD group, after intermittent theta burst stimulation vs. baseline | Plasma | Human | Down |
| Study M472 | Type3 | (2R,6R)-HNK group vs. control group | PC12 cell | Rat | Down |
| Study M472 | Type3 | (2S,6S)-HNK group vs. control group | PC12 cell | Rat | Down |
| Study M981 | Type2 | Abeta oligomer + involuntary and voluntary running + acousto-optic stimulation group vs. Abeta oligomer group | Serum | ICR mouse | Down |